Commentary

GE is a crucible of management talent and a producer of CEOs that rivals universities. Now GE is embarking on a new challenge – producing organic (internally-generated) growth....

With apologies (we think) to Donald Trump, columnist Paul Gibler explains why no marketer can ignore the benefits of publishing content using Really Simple Syndication (RSS). While implementation is still weak among companies with $50 million or more in annual sales, a majority (63 percent)...

Taking a few jabs at Washington, Gov. Jim Doyle makes the case for his alternative fuels plan. In what he is labeling a "Declaration of Energy Independence," the governor is calling for 25 percent of the state's power and 25 percent of its transportation fuels...

Columnist Chris Shipley offers up three perfect summer "reads" that will provide something interesting, insightful, and entertaining to take to the beach. The topics of these page-turners include brand marketing, business innovation, and some lighter fare in the form of a Silicon Valley murder mystery....

Big Pharma continues to face substantial sales and profit declines, with drugs losing patent protection, and there is a new twist on how Big Pharma will manage the loss of patent exclusivity. But pharma's stocks are still healthier than those of its biotech cousins....

From blogs to wikis, Web 2.0 concepts could be adopted as part of your business strategy. But as Paul Gibler explains in this debut Buzz Networks column, you've got to keep track of them in order to explore all the possibilities....